| Resistance to molecularly targeted therapies in melanoma M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein, K Lam, N Puri Cancers 13 (5), 1115, 2021 | 63 | 2021 |
| Treatment of metastatic melanoma with a combination of immunotherapies and molecularly targeted therapies T Rager, A Eckburg, M Patel, R Qiu, S Gantiwala, K Dovalovsky, K Fan, ... Cancers 14 (15), 3779, 2022 | 34 | 2022 |
| Oligonucleotides and microRNAs targeting telomerase subunits in cancer therapy A Eckburg, J Dein, J Berei, Z Schrank, N Puri Cancers 12 (9), 2337, 2020 | 25 | 2020 |
| Mediating EGFR-TKI resistance by VEGF/VEGFR autocrine pathway in non-small cell lung cancer C Osude, L Lin, M Patel, A Eckburg, J Berei, A Kuckovic, N Dube, ... Cells 11 (10), 1694, 2022 | 24 | 2022 |
| Potential telomere-related pharmacological targets J Berei, A Eckburg, E Miliavski, AD Anderson, RJ Miller, J Dein, ... Current Topics in Medicinal Chemistry 20 (6), 458-484, 2020 | 22 | 2020 |
| EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer ZD Crees, C Shearrow, L Lin, J Girard, K Arasi, A Bhoraskar, J Berei, ... Therapeutic advances in medical oncology 12, 1758835920953731, 2020 | 13 | 2020 |
| Nutritional needs, resources, and barriers among unhoused adults cared for by a street medicine organization in Chicago, Illinois: a cross-sectional study EJ Adams, M Lu, R Duan, AK Chao, HC Kessler, CD Miller, AG Richter, ... BMC public health 23 (1), 2430, 2023 | 5 | 2023 |
| Resistance to Molecularly Targeted Therapies in Melanoma. Cancers 2021, 13, 1115 M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein, K Lam, N Puri s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 3 | 2021 |
| PATH-61. NGS DATA INFLUENCE ON CLINICIAN DECISION-MAKING ACROSS PRIMARY BRAIN TUMORS AT NORTHWESTERN UNIVERSITY A Eckburg, J John, P Kumthekar Neuro-Oncology 25 (Suppl 5), v182, 2023 | | 2023 |
| Investigating the impact of NGS data availability on clinical decision-making in brain cancer. A Eckburg, J John, P Kumthekar Journal of Clinical Oncology 40 (16_suppl), 2032-2032, 2022 | | 2022 |
